2021
Puyade, M., Patel, A., Lim, Y. J., Blank, N., Badoglio, M., Gualandi, F., . . . Snowden, J. A. (2021). Autologous Hematopoietic Stem Cell Transplantation for Behcet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. In FRONTIERS IN IMMUNOLOGY Vol. 12. doi:10.3389/fimmu.2021.638709DOI: 10.3389/fimmu.2021.638709
2020
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival (Journal article)
Martinez-Calle, N., Poynton, E., Alchawaf, A., Kassam, S., Horan, M., Rafferty, M., . . . Cwynarski, K. (2020). Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival. BRITISH JOURNAL OF HAEMATOLOGY, 190(3), 394-404. doi:10.1111/bjh.16592DOI: 10.1111/bjh.16592
Ruxolitinib in myelofibrosis: a multicentre analysis of real-world patients in England, Northern Ireland and Wales (Conference Paper)
Russell, J., Wright, C., Sparksman, D., Waddell, D., Daly, A., Fisken, R., . . . Sadullah, S. (2020). Ruxolitinib in myelofibrosis: a multicentre analysis of real-world patients in England, Northern Ireland and Wales. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 189 (pp. 81-82). Retrieved from https://www.webofscience.com/
2019
Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival (Conference Paper)
Poynton, E., Martinez-Calle, N., Alchawaf, A., Kassam, S., Horan, M., Rafferty, M., . . . Fox, C. (2019). Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 185 (pp. 28-29). Retrieved from https://www.webofscience.com/
2018
Long-Term Safety and Efficacy of Autologous or Allogeneic Donor Stem Cell Transplantation in Patients with Behcet's Syndrome (Conference Paper)
Patel, A., & Lim, Y. J. (2018). Long-Term Safety and Efficacy of Autologous or Allogeneic Donor Stem Cell Transplantation in Patients with Behcet's Syndrome. In BLOOD Vol. 132. doi:10.1182/blood-2018-99-115815DOI: 10.1182/blood-2018-99-115815
Randomized Trials of Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Systematic Review and Meta-Analysis with Trial Sequential Analysis of Overall Mortality (Conference Paper)
Patel, A., & Lim, Y. J. (2018). Randomized Trials of Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Systematic Review and Meta-Analysis with Trial Sequential Analysis of Overall Mortality. In BLOOD Vol. 132. doi:10.1182/blood-2018-99-115326DOI: 10.1182/blood-2018-99-115326
Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival (Conference Paper)
Martinez-Calle, N., Poynton, E., Alchawaf, A., Kassam, S., Horan, M., Rafferty, M., . . . Cwynarski, K. (2018). Real-World Outcomes of Older Patients with Primary Central Nervous System Lymphoma (PCNSL): Methotrexate Dose Intensity and Combination with Cytarabine Correlate with Response and Survival. In BLOOD Vol. 132. doi:10.1182/blood-2018-99-111901DOI: 10.1182/blood-2018-99-111901
Ruxolitinib in Myelofibrosis: a multicentre experience in England, Northern Ireland and Wales (Conference Paper)
Russell, J., Daly, A., Fisken, R., Dicu, A., Cunningham, J., Sparksman, D., . . . Sadullah, S. (2018). Ruxolitinib in Myelofibrosis: a multicentre experience in England, Northern Ireland and Wales. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 181 (pp. 10). Retrieved from https://www.webofscience.com/
Utility of 18F-FDG PET/CT in the diagnosis and assessment of myeloma associated bone disease: a single centre experience (Conference Paper)
Lim, Y. J., Taheri, A., Fernando, R., Seshadri, N., Brearton, G., & Hawkins, S. (2018). Utility of 18F-FDG PET/CT in the diagnosis and assessment of myeloma associated bone disease: a single centre experience. In BRITISH JOURNAL OF HAEMATOLOGY Vol. 181 (pp. 105-106). Retrieved from https://www.webofscience.com/
2017
TREATMENT OF NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS BASED ON COMORBIDITIES & PERFORMANCE STATUS: A SINGLE-CENTRE EXPERIENCE (Conference Paper)
Lim, Y. J., & Smith, J. (2017). TREATMENT OF NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS BASED ON COMORBIDITIES & PERFORMANCE STATUS: A SINGLE-CENTRE EXPERIENCE. In HAEMATOLOGICA Vol. 102 (pp. 699). Retrieved from https://www.webofscience.com/
